Drugs / Jialeban
Jialeban
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06977750 | Apr → Oct 2025 overdue | — | Nanjing Chia-tai Tianqing Pharmaceutical | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jialeban | “The succinylated gelatin electrolyte sodium acetate injection (trade name: Jialeban) produced and licensed by Braun Medical (Suzhou) Co., Ltd ®； Specification: 500 mL: 20 g) is...” NCT06977750 ↗ |
| Known as | succinylated gelatin electrolyte sodium acetate injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06977750 ↗ |